Next Article in Journal
Composition and Anticoagulant Potential of Chondroitin Sulfate and Dermatan Sulfate from Inedible Parts of Garfish (Belone belone)
Previous Article in Journal
Effects of Blanching, Freezing and Canning on the Carbohydrates in Sweet Corn
Previous Article in Special Issue
Antioxidant, Antihypertensive, Hypoglycaemic and Nootropic Activity of a Polyphenolic Extract from the Halophyte Ice Plant (Mesembryanthemum crystallinum)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 12
Issue 21
10.3390/foods12213886
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Identification of Polyphenols in Sea Fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) Extracts with Antioxidant, ACE-I, DPP-IV and PEP-Inhibitory Capacity

by
Marta María Calvo
,
María Elvira López-Caballero
and
Oscar Martínez-Alvarez
*
Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), 6th José Antonio Novais St., 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Foods 2023, 12(21), 3886; https://doi.org/10.3390/foods12213886
Submission received: 3 October 2023 / Revised: 17 October 2023 / Accepted: 20 October 2023 / Published: 24 October 2023
(This article belongs to the Special Issue Applications of Technological and/or Bioactive Ingredients Derived from Halophytes, Marine Plants or Algae in Foods)
Browse Figures
Review Reports Versions Notes

Abstract

:
Sea fennel and seaside arrowgrass are two abundant but underutilized halophytes along the Atlantic and Mediterranean coasts. This study investigated the antioxidant capacity and the potential antihypertensive (Angiotensin Converting Enzyme I, ACE-I inhibition), hypoglycaemic (Dipeptidyl Peptidase IV, DPP-IV inhibition), and nootropic (Prolyl Endopeptidase, PEP inhibition) activity of their polyphenol extracts. They had a high phenol content (21–24 mEq GA/g), antioxidant capacity evaluated using the ABTS (17–2 mg ascorbic acid/g) and FRAP (170–270 mM Mohr’s salt/g) assays, and effective ACE-inhibiting properties (80–90% inhibiting activity at final concentration of 0.5 mg/mL). Additionally, the sea fennel extract displayed high DPP-IV inhibitory capacity (73% at 1 mg/mL), while the seaside arrowgrass extract exhibited potent Prolyl endopeptidase inhibitory capacity (75% at 1 mg/mL). Fractionation by HPLC concentrated the bioactive molecules in two fractions, for which the composition was analyzed by LC-MS/MS. Different chlorogenic acids seemed to play an important role in the bioactivity of sea fennel extract, and different flavonoids, mainly apigenin, luteolin and chrysoeriol, in the bioactivity of the seaside arrowgrass extract. Given their potential health benefits, these extracts could serve as valuable bioactive ingredients and could potentially encourage the cultivation of these species in regions where traditional crops face challenges in growth.

1. Introduction

Preserving edible plant species and improving their cultivation is a priority for the agri-food sector. This need is being driven by climate change, which is affecting the entire world. This challenge is being addressed in different ways, such as using varieties that can withstand water stress, increasing the cultivation of drought-resistant species, or those that can be irrigated with high saline water or even seawater. In addition, climate change is increasing land salinity. This problem affects an estimated 1 billion hectares of land, corresponding to 20% of the world’s cultivated soil [1,2], and 50% of the irrigated area [3].
The problems that climate change is causing in crop production can be addressed by introducing or improving the cultivation of halophytes. Halophytes comprise more than 350 species in 20 orders and 256 families, representing 1–2% of the world’s flora [4]. These plants are adapted to environments with salinity levels equal to or higher than 200 mM NaCl and do not require fresh water. This allows them to grow in areas where only saltwater is available. Some species are suitable for human consumption and could be good candidates for large-scale introduction as edible crops, especially in very arid regions where they could be the main (if not the only) feed resource available [1,5,6,7]. Halophytes are not only a good source of nutrients, but also of bioactive compounds. Some species have been used in traditional medicine to treat various diseases [8,9]. Some of the biological activities of halophytes that have been reported include antioxidant, anticholinesterase, anticancer, antimicrobial, anti-inflammatory, analgesic, astringent, diuretic, antipyretic, vasoactive, antibacterial, and cytotoxic [7,10,11].
Sea fennel (Crithmum maritimum) is one of the most abundant halophytes in Europe. It is commonly found along the coasts of Southern and Western Europe, and can also be found in other parts of the world [12]. Sea fennel is capable of thriving in salt-free or low saline soils. The nutritional composition of sea fennel was recently described by Sánchez-Faure et al. [13], who reported a high content of calcium and dietary fiber. Its tender leaves and stems are used in salads, pickles, appetizers, and condiments [12,14]. In addition, sea fennel is abundant in bioactive compounds. Recently, extracts from this plant have been used as a functional ingredient to enrich sunflower oil [15]. Sea fennel has also been utilized to obtain essential oils and in traditional medicine [12,16,17,18]. The potential of this plant as a nutraceutical for preventing and treating certain human diseases has been documented due to the presence of antioxidant molecules [19,20], antimicrobials [19,21], antimutagenics [19], vasodilators [20], and cholinesterase inhibitors [20], among others.
Seaside arrowgrass (Triglochin maritima) is a common halophyte found in the marshlands of Northern Europe and in the coastal areas of Mediterranean countries. Their nutrient composition has also been recently documented [13]. This plant contains molecules of interest such as fatty acids, amino acids, organic acids, mono- and disaccharides, polyols and polyphenols with health-promoting properties [13,22]. Likewise, there is limited knowledge about the beneficial effects that its consumption could have on human health. The utilization of this plant as a source of bioactive compounds has hardly been reported. A recent study by Boestfleisch and Papenbrock [23] investigated the production of secondary metabolites with antioxidant capacity in seaside arrowgrass under different conditions of soil salinity. They found that the production of these metabolites was increased under conditions of high soil salinity. This suggests that seaside arrowgrass can be used as a source of antioxidants, which are of interest to protect cells from free radical damage.
Halophytes are exposed to high stress situations that result in the production of antioxidant compounds, including polyphenols [24]. Polyphenols do not show significant toxicity or harmful effects on the human body and have promising therapeutic potential [25]. Several polyphenols have the ability to inhibit angiotensin-converting enzyme (ACE), an enzyme linked to the development of hypertension [26,27,28,29,30]. In addition, previous research has described the potential hypoglycemic capacity of polyphenols through their inhibitory effect on dipeptidyl peptidase IV (DPP-IV) [28,31,32,33]. Additionally, some polyphenols are effective inhibitors of prolyl endopeptidases (PEP) [28,34,35,36], a family of enzymes that can hydrolyze hormones such as vasopressin, thyrotropin-releasing hormone, or substance P. Some researchers have suggested that PEPs may present a viable pharmacological target for treating various neurological conditions linked to abnormally high serum PEP activity, including Alzheimer’s disease, schizophrenia, and depression, as well as other disorders like anorexia and bulimia [37].
In certain areas where salinization of agricultural land and freshwater shortages are reducing crop yields, halophytes offer an alternative to traditional crops. Many studies have focused on evaluating the growth and yield of halophyte crops, as well as the impact of their cultivation on soil and water quality. Others have focused on characterizing their nutritional profile and the study of their potential for animal and human consumption. However, their potential as a potent and natural source of bioactive molecules is poorly documented. In this context, this study aims to explore the potential of two halophytes abundant in the European and Mediterranean coasts, seaside arrowgrass and sea fennel, as a source of molecules of nutraceutical interest against diseases of high prevalence in developed countries. More specifically, this study is focused on the analysis of the antihypertensive, nootropic, hypoglycemic and antioxidant potential of ethanolic extracts of these two plants, as well as on the isolation and identification of the polyphenols potentially responsible for these activities.

2. Materials and Methods

2.1. Chemicals

Folin–Ciocalteu reagent, gallic acid (GA), 2,2′-azino-bis-(3-ethylbenzothiazoline-6- sulphonic acid) (ABTS), 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ), ammonium iron (II) sulphate, human dipeptidyl peptidase-IV, angiotensin-converting enzyme from rabbit lung, and reagents used for HPLC analysis were purchased from Sigma-Aldrich, Co. (St. Louis, MO, USA). Seikagaku Corp. (Tokyo, Japan) provided prolyl endopeptidase from Flavobacterium. Chromogenic substrates were purchased from Bachem (Bubendorf, Switzerland). Ethylenediaminetetraacetic acid (EDTA) was from Leco Corp. (St. Joseph, MI, USA). Analytical-grade chemicals and reagents were purchased from Panreac Chemical Co. (Barcelona, Spain).

2.2. Plant Processing

The company Porto-Muiños S.L. (Cedeira, A Coruña, Spain) collected sea fennel and seaside arrowgrass on the coast of Galicia, in north-western Spain. The samples were transported at a low temperature (4 °C) to Madrid. The edible portions (leaves and stems) underwent a washing process involving distilled water and then were subjected to drying via forced air oven (FD 240, Binder, Tuttlingen, Germany) at 55 °C for 24 h. The dried plants were then stored at 4 °C until analysis.

2.3. Preparation of the Extract

The preparation of the extract was in accordance with the method of Calvo et al. [28]. The dried samples (250 g) were homogenized in a 400 mL mixture of ethanol/water 1/1 (v/v) at pH 2, in a ratio of 1:2 (w/v) using an Ultra-Turrax homogenizer (Mod. T25D, IKA®-Werke GmbH & Co. KG, Staufen, Germany) at 25,000× g for 3 min at 25 °C. The homogenates were kept in an ice bath and then sonicated in 16 cycles at 90% amplitude, with 60 s of interval between each cycle of 1 min. After extraction, the samples were centrifuged at 12,000× g for 10 min at 5 °C (Sorvall evolution, Thermo Fisher Scientific, Waltham, MA, USA). The supernatants were evaporated using a rotary evaporator (R-300, BÜCHI, Buchegg, Switzerland) until the ethanol was eliminated. Then, the extracts were freeze-dried and stored at 4 °C until analysis.

2.4. Determination of Total Phenol Content

The total phenolic content of the extracts was determined using the Folin–Ciocalteau assay, in accordance with the procedure outlined by Calvo et al. [28]. The extracts were dissolved in distilled water to a concentration of 10 mg/mL (dry weight). The extracts were then mixed (1/1, v/v) with 500 µL of Folin reagent, 10 mL of 0.7 M Na2CO3, and 14 mL of distilled water. The mixtures were stirred for 1 h at room temperature, and the absorbance was then measured at 750 nm using a spectrophotometer Shimadzu UV-1601 (Kyoto, Japan). Gallic acid (0.05–0.3 mg/mL) was used as standard. The results were expressed as mg Eq GA/g (dry weight).

2.5. Scavenging Activity of ABTS Radical Cation

The radical scavenging activity of the fractions and the extract was performed according to Calvo et al. [28]. First, an ABTS+ stock solution was prepared by mixing 7 mM aqueous ABTS+ and 2.45 mM K2O8S2 in a 1:1 (v/v) ratio. After 16 h in the dark, the mixture was diluted in distilled water to reach an absorbance of 0.70 ± 0.02 at 734 nm. Then, 980 µL of ABTS+ working solution was mixed with 20 µL of sample diluted in distilled water (10 mg of extracts/mL or 1 mg of fraction/mL, dry weight). The mixture was incubated for 10 min at 30 °C in the dark. The absorbance was then measured at 734 nm using a spectrophotometer. Ascorbic acid (0.02–0.6 mg/mL) was used as standard. The results were expressed as mg Eq ascorbic acid/g (dry weight).

2.6. Ferric Reducing Antioxidant Power (FRAP)

The ferric-reducing antioxidant power of the fractions and the extract was analyzed following the protocol of Calvo et al. [28]. To prepare the FRAP reagent, 25 mL of 0.2 M sodium acetate buffer (pH 3.6), 2.5 mL of 10 mM TPTZ (dissolved in 40 mM HCl), and 2.5 mL of 20 mM FeCl3 were mixed. Afterwards, 900 µL of FRAP reagent was combined with 90 µL of distilled water and 30 µL of sample (10 mg of extract or 1 mg of fraction/mL, dry weight), and incubated at 37 °C for 30 min in the dark. The absorbance was measured at 595 nm using a spectrophotometer. Ammonium iron (II) sulphate, also known as Mohr’s salt, was used as a standard at concentrations ranging between 0.1 to 1 mM. The results were expressed as mEq Mohr’s salt per gram of dry weight.

2.7. Determination of ACE Inhibitory Activity

The ACE inhibitory activity was measured according to Sentandreu and Toldrá [38] with some modifications. To prepare the enzyme, it was dissolved in a Tris-base buffer (150 mM, pH 8.3, containing 1.125 M NaCl). The final enzymatic activity was 15 mU/mL. The samples (final concentration of 0.5 mg of dried extract/mL or 0.1 mg of dried fraction/mL in the system) and the substrate (0.45 mM Abz-Gly-Phe(NO2)-Pro) were also dissolved in the same buffer. A mixture consisting of 50 µL of either sample or buffer (control) and 50 µL of ACE was incubated at 37 °C for 15 min. The reaction was started by adding 200 µL of substrate and continued for 15 min. The fluorescence was measured at λexc 360 nm and λem 400 nm using a Sinergy Mx microplate reader (BioTeck, Colmar, France). The maximum linear increase in fluorescence per minute was determined for each well and inhibition activity was expressed as a percentage.

2.8. Determination of PEP Inhibitory Activity

PEP-inhibitory activity was measured in 96-well plates, as according to Sila et al. [35]. In each well, 20 μL of enzyme (1 mU) was mixed with either 180 μL of 0.1 M sodium phosphate buffer pH 7 (assay buffer) or 150 μL of buffer, together with 30 μL of the sample diluted in buffer. The final concentration of sample in the system was 1 mg of dried extract/mL or 0.2 mg of dried fraction/mL. The plate was incubated at 37 °C for 15 min. Then, 100 μL of 0.01 mM Z-Gly-Pro-AMC was added. The microplate reader monitored fluorescence at λexc 340 nm and λem 450 nm every 1 min for 20 min. The inhibitory activity was expressed as a percentage of the inhibition, as outlined in Section 2.7.

2.9. Determination of DPP-IV Inhibitory Activity

The DPP-IV-inhibition was determined as described by PEP-activity, but with 0.1 M Tris-HCl (pH 8) as buffer assay, following the protocol outlined by Sila et al. [35]. The substrate used was 0.025 mM H-Gly-Pro-AMC·HBr. The inhibiting activity of the samples was calculated as indicated in Section 2.7.

2.10. Chromatographic Fractionation of the Extracts

The extracts were fractionated following the method of Calvo et al. [28]. The extracts were firstly reconstituted to a concentration of 80 mg/mL (dry weight) in a mixture of ethanol and water (1/1, v/v). A preparative HPLC system (Agilent LC PREP 1260 Infinity Series, Santa Clara, CA, USA) equipped with a diode array detector (DAD) and a Tracer Excel 120 ODS-A 25 × 0.78 cm preparative C18 column (Teknokroma, Barcelona, Spain) was used. Phase A was comprised of ultrapure water containing 5% acetonitrile and 0.1% formic acid, while phase B consisted of acetonitrile with 0.1% formic acid. The gradient used consisted of four steps: 0–15% B for the first 15 min, 15–50% B for the following 5 min, 50–65% B for the next 15 min, and finally 65–0% B for the last 10 min. The flow rate was maintained at 2 mL/min. Fractions were automatically collected using a fraction collector while detection was performed at 280 and 360 nm. The collected fractions underwent solvent evaporation in a Speed Vac concentrator (Thermo Fisher, Waltham, MA, USA). Then, the fractions were lyophilized and stored at 4 °C until use.

2.11. Tentative Identification of Polyphenols by HPLC-ESI-QTOF-MS

The fractions showing the highest bioactivity were selected and the polyphenols were extracted using Oasis® HLB cartridges (Waters, Milford, MA, USA). The separation of the polyphenols was performed using high-performance liquid chromatography coupled with electrospray ionization and quadrupole time-of-flight mass spectrometry (HPLC-ESI-QTOF-MS) as described by Sánchez-Faure et al. [13]. The mass spectra were obtained by electrospray ionization in negative mode. The gas temperature was 325 °C and the drying gas flow was 12 L/min. A range of 100 to 1200 m/z was used to scan the acquisition for auto MS/MS. The mass spectra were analyzed with MassHunter Workstation version 4.0 software (Agilent Technologies, Santa Clara, CA, USA). The phenolic compounds were identified by comparing their experimental mass with the mass obtained in the negative mode analysis, allowing an error of 8 ppm. The fragmentation pattern and the relative abundance of fragment ions obtained for each compound were also compared with some databases such as MassBank, Food Database and Human Metabolome Database.

2.12. Statistical Analysis

A student’s t-test was used to compare the bioactivity of the extracts from sea fennel and seaside arrowgrass. The bioactivity of the fractions was compared using the one-way analysis of variance (ANOVA) method. The software program SPSS 27 (IBM Corporation, Armonk, NY, USA) was used to perform the statistical analysis. The level of significance was set at p ≤ 0.05. All measurements were taken three times to ensure accuracy.

3. Results and Discussion

3.1. Phenolic Content and Bioactivity of the Extracts

3.1.1. Phenolic Content

The phenolic content of the sea fennel and seaside arrowgrass extracts was 23.6 and 21.2 mg Eq GA/g, respectively (Table 1). According to Kähkönen et al. [39], these plants can be considered rich in phenols, as they have values above 20 mg Eq GA/g. The high phenol content in halophytes has been previously described by several authors, such as Lopes et al. [9]. Their synthesis and accumulation are a response to abiotic stress situations such as extreme temperatures, salinity, sodicity and alkalinity of soils, or flood and anoxia situations. The phenol content can also be increased by exposure to biotic threats [9].
The phenolic content found in the sea fennel extract was higher than that reported by Houta et al. [40] (11.5 mg GA/g) and Sánchez-Faure et al. [13] (3.6 mEq GA/g). Kraouia et al. [12] reviewed the phenolic content reported by different authors for sea fennel extracts obtained with different solvent mixtures (acetone, methanol or ethanol with water) and, in almost all cases, the values were lower than that obtained in this work. Extracts with a slightly higher phenol content have been obtained using methanol/water (up to 33 mg GA/g) [41] and ethanol/water and microwaves (26–29 mg GA/g) [42]. Concerning the phenolic content of seaside arrowgrass, it was higher than those reported by Lee et al. [22], 3.3 mg GA/100 g, and Sánchez-Faure et al. [13], 5.9 mg GA/g. All these differences can be attributed to different factors, such as the stress conditions, the habitat, the organ selected for extraction, the genotype, the vegetative state, the extraction parameters and the polarity indexes of the different solvent mixtures used [9,12,13].

3.1.2. Antioxidant Activity

ABTS and the FRAP assays were used to determine the antioxidant activity. Both methods are based on electron transfer. The ABTS assay measures the ability of a compound to scavenge free hydrophilic radicals, while the FRAP assay measures the ability of a compound to donate electrons to free radicals, converting them into more stable products and thus terminating the free radical chain reaction [43].
The antioxidant activity of the sea fennel extract was slightly higher than that of the seaside arrowgrass extract in both assays. The ABTS assay results ranged from 17.4–20.6 mg Eq ascorbic acid/g, while the FRAP assay results ranged from 170–269 mEq Mohr salt/g. Kadoglidou et al. [44] and Meot-Duros and Magné [41] also obtained sea fennel extracts with radical scavenging activity. Nabet et al. [45] reported a lower antioxidant capacity, with values of 0.43 mg TE/g. Lee et al. [22] determined the antioxidant capacity of ethanolic extracts of six halophytes using the DPPH assay, and found that seaside arrowgrass had similar or higher antioxidant activity than different Salicornia species. The content of antioxidant enzymes, phenolic compounds, carotenoids, and chlorophylls could be responsible for the potential antioxidant activity of the sea fennel and the seaside arrowgrass extracts. However, phenolic compounds appear to be a primary factor in the antioxidant activity of the extracts, according to Zengin et al. [46], who noted their effects on radical scavenging and reducing power mechanisms in seven Apiaceae species.

3.1.3. Enzyme Inhibitory Capacity of the Ethanolic Extracts

The ACE inhibitory capacity of sea fennel and seaside arrowgrass extracts was remarkable, especially for the seaside arrowgrass extract, with values of around 90% inhibition at a final concentration of 0.5 mg/mL (Table 1). The ability of halophyte extracts to inhibit enzymes involved in various human pathologies, such as ACE, has been poorly described. Calvo et al. [28] described the ACE inhibitory capacity of an ethanolic extract of the halophyte ice plant, reaching a high inhibition (90.5%) but at higher final concentration (1 mg/mL) than that tested in this work. Loizzo et al. [47] reported an important ACE inhibitory activity of different ethyl acetate extracts of several halophytes belonging to the genus Salsola (IC50 values among 0.18–0.28 mg/mL).
The ACE inhibitory activity of halophyte plant extracts could be associated with the presence of certain terpenoids, alkaloids, tannins, proanthocyanidins and flavonoids. Men et al. [48] attributed the ACE inhibitory capacity of different extracts obtained from Suaeda physophora to the presence of polyphenols, although this capacity was much lower than that of the sea fennel and seaside arrowgrass extracts. Shukor et al. [49] investigated the ACE inhibitory capacity of phenolic compounds, observing different modes of action. The antihypertensive capacity of polyphenols has also been studied in vivo [50], with this effect attributed not only to their ability to inhibit ACE, but also to other mechanisms [50,51]. However, information regarding the in vivo antihypertensive effect of halophyte extracts is limited. Sharifi et al. [52] and Phillips et al. [53] observed an antihypertensive effect of Gokshur (Tribulus terrestris) extracts in experimental animals, which was attributed to their ability to inhibit ACE as well as the release of nitric oxide.
The extracts showed high DPP-IV inhibiting capacity (68–73%) with a significantly higher potency of the sea fennel extract (Table 1). Some authors have observed the hypoglycemic activity of halophyte extracts in vivo, but this has been attributed to mechanisms other than DPP-IV inhibition [54].
The seaside arrowgrass and sea fennel extracts showed a high PEP-inhibiting capacity, especially the former (Table 1). This capacity, although high, was lower than that described for an ethanolic extract of the halophyte ice plant at the same final concentration of 1 mg/mL (98%) [28]. The inhibition of PEP by halophyte extracts has received limited description, and may be associated with specific polyphenols, primarily flavonoids, as well as cyclotides and alkaloids [55,56,57].

3.2. Characterization and Bioactivity of the Fractions

The sea fennel extracts therefore displayed significant potential as antihypertensive, hypoglycemic and antioxidant agents (Table 1). To isolate and identify the molecules potentially responsible for the bioactivity, the extracts were chromatographically fractionated, and the potentially bioactive activity of each fraction was further analyzed.
Each extract was separated into four fractions (Figure 1 and Figure 2). Table 2 revealed a strong correlation between the bioactive potential and phenol content in both extracts, suggesting that the bioactive molecules in each extract were likely polyphenols. The molecules with the strongest ACE inhibitors and antioxidants were concentrated in SF-3, SF-4, SA-3, and SA-4. SF-3 and SF-4 concentrated the most significant DPP-IV inhibitors, and SA-3 and SA-4 the most potent PEP inhibitors. These four fractions were chosen to determine their polyphenol composition and role in the analyzed bioactive activities.

3.2.1. Identification of Potential Bioactive Polyphenols Present in the Factions

The polyphenolic composition of SF-3 and SF-4 was similar, as shown in Table 3. Some of the identified polyphenols were also found in an extract of sea fennel collected from the same coast [13], using sequentially ethanol/water (1/1, v/v) and acetone/water (7/3, v/v) as solvent extraction mixtures. Both SF-3 and SF-4 exhibited a high concentration of hydroxycinnamic acids, mainly isochlorogenic acids (Table 4). This was especially remarkable in SF-3, where 91% of the total polyphenols were hydroxycinnamic acids. This fraction predominantly consisted of caffeoylquinic acids (41.7%), coumaroylquinic acids (30.2%), and feruloylquinic acids (12.6%), which accounted for approximately 84–85% of the total polyphenols identified. SF-4 contained less hydroxycinnamic acids (67.9%), with coumaroylquinic acids (29.9%), feruloylquinic acids (13.26%) and dicaffeoylquinic acids (13.12%) contributing to 56.4% of the total polyphenols in the fraction. Other authors have also identified chlorogenic acids as the primary components in sea fennel extracts [12,16,19,20,41,42,58,59]. The caffeoylquinic acids present in SF-3 and SF-4 might correspond to 1, 3, 4 and 5-caffeoylquinic acids. Kraouia et al. [12] also reported the presence of major isomers of caffeoylquinic acid in extracts from leaves and stem tissues of sea fennel collected from various regions. Additionally, SF-3 and SF-4 contained four isomers of dicaffeoylquinic acid (mainly in the latter, 13.12%), but at a low relative concentration. Four coumaroylquinic acid isomers (2, 3, 4 and 5-coumaroylquinic acids, around 30%) and two feruloylquinic acid isomers (around 13%) were also found in both fractions. Furthermore, SF-4 contained approximately 31% of flavonoids, predominantly quercetin glycosides (12.15%) and rutin (7.18%). Rutin has been previously found in sea fennel extracts [16,42], as well as quercetin-3-O-galactoside [16]. Furthermore, SF-3 and SF-4 contained other polyphenols (Table 3 and Table 4), but their relative content was minimal.
The polyphenolic profiles of seaside arrowgrass fractions SA-3 and SA-4 differed significantly from those of SF-3 and SF-4 (Table 5). Both SA-3 and SA-4 consisted almost entirely of flavones and derivatives, but there were notable differences in their composition. SA-3 was mainly composed of apigenin 6-hexoside (80.5% of the total), followed by luteolin (8.5%) (Table 6). In contrast, SA-4 was mainly composed of apigenin (52.4%), luteolin (34.7%) and chrysoeriol (12.8%). Sánchez-Faure et al. [13] analyzed the polyphenol profile of a seaside arrowgrass extract harvested in the same area, and discovered a predominance of flavones and flavonols. However, they observed a significant abundance of isoorientin (a glycosylated luteolin) in the extract.

3.2.2. Antioxidant Activity of the Fractions

Fractions SF-3, SF-4, SA-4 and SA-3 (in that order) showed the most potent antioxidant activity (Table 2), as determined by the ABTS or FRAP assays. Table 2 demonstrates a positive correlation between the antioxidant capacity of the fractions and their phenol content, as observed by Lee et al. [22], suggesting that phenolic compounds were the main compounds responsible for the antioxidant activity.
The antioxidant activity of SF-3 and SF-4 was mainly ascribed to the presence of chlorogenic acids. It was also observed by Siracusa et al. [60] in other sea fennel extract. The hydroxyl groups on the aromatic ring (Figure 3) have been associated with the antioxidant properties of these hydroxycinnamic acids, reflecting the facilitating of hydrogen atom donation, which effectively inhibits radical chain reactions and other oxidants, and the ability to act as chelators of transition metals, preventing Fenton-type processes [61,62]. Xu et al. [61] compared the antioxidant activity of different chlorogenic acid isomers. They found that the dicaffeoylquinic acids had better antioxidant activity than caffeoylquinic acids due to additional OH groups being attached to the aromatic ring in their structure. Moreover, flavonoids such as flavonols, flavones, and their derivatives, primarily rutin, may play a significant role in the antioxidant activity of SF-4 [63], as also observed by Siracusa et al. [60]. Myricetin, though present in a low relative concentration, could also contribute to the antioxidant activity of SF-4 [64].
SA-4 and SA-3 exhibited considerable antioxidant activity, but it was lower than that of SF-3 and SF-4 (Table 2). The antioxidant activity of SA-3 and SA-4 was attributed to the abundance of flavones and derivatives.
SA-4 exhibited a significant greater level of antioxidant activity compared to SA-3, which may be due to its higher polyphenol content and/or its relatively higher levels of apigenin, luteolin and chrysoeriol content. The antioxidant activity of flavonoids depends on the number and position of OH groups within their structure, as well as the presence of electron-withdrawing or electron-donating substituent groups [62,65]. The antioxidant activity of apigenin has been recently reviewed by Kashyap et al. [66], and has been demonstrated in vitro and in animal trials. Apigenin is a potent inhibitor of several oxidant enzymes, including cyclooxygenase, nitric oxide synthase, xanthine oxidase, nitric oxide, and lipoxygenase. Additionally, it can interact with redox signaling pathways, and scavenge free radicals through two pathways: hydrogen atom transfer (HAT) and single electron transfer (SET). This effect is due to OH groups present in the structure at the 4′ position of the phenolic B-ring and the 5 and 7 positions of the A-ring [67] (Figure 4). These groups donate their hydrogen atoms and electrons to the hydroxyl, peroxyl and peroxynitrite radicals, rendering them stable and generating stable radicals. The presence of a C2-C3 double bond and a carbonyl group at the 4 position of the pyranyl C-ring (1,4 pyrone moiety) enhances the antioxidant activity by enabling the delocalization of unpaired electrons across the A-, B- and C-rings. It leads to the formation of a more stable phenoxyl radical. Similarly, the antioxidant activity of chrysoeriol (an apigenin with a methoxy group in 3′ position of the B-ring) can also be attributed to these same groups. Regarding luteolin, its antioxidant capacity is due to the presence of the 1,4-pyrone moiety and OH groups, including an additional one in the 3’ position of the B-ring (Figure 4) [68].

3.2.3. Enzyme Inhibitory Activities of the Bioactive Fractions

ACE-Inhibitory Activity

SF-3, SF-4, SA-3 and SA-4 displayed potent ACE inhibitory capacity (Table 2). Significant differences were observed among samples, showing SF-E the most potent inhibiting effect. The considerable content of chlorogenic acids in SF-3 and SF-4 (especially in SF-3) indicates their vital contribution to the ACE-inhibitory potential of the sea fennel extract. Agunloye et al. [69] observed that intraperitoneal administration of caffeoylquinic acid in hypertensive rats resulted in a lowering of blood pressure and ACE-inhibiting activity. The reduction in ACE activity was attributed to a decrease in vascular ACE synthesis and secretion, or to ACE inhibition. The ACE-inhibitory activity of the chlorogenic acids could be due to the OH groups in the benzene ring, which interact with zinc ions and disulfide bridges at the active site of ACE [70,71]. Thus, dicaffeoylquinic acids, with four OH groups on the benzene rings, display significant ACE inhibition, in contrast to coumaroylquinic acids, with only one OH group. Moreover, the carboxylate moieties in the hydroxycinnamic acids enhance ACE inhibition by promoting a charge–charge interaction with the zinc ion at the ACE active site via the oxygen atom [49]. In contrast, methylation of an OH group, as observed in 3-feruloylquinic acid, decreases the ACE inhibitory capacity through steric hindrance that obstructs the binding to the ACE active site [72]. Flavones, flavonols and their derivatives (especially quercetin, rutin and apigenin) in SF-3 and SF-4 also exhibit a certain ACE-inhibitory activity [49]. However, despite their greater presence in SF-4, it did not result in a higher bioactivity when compared with SF-3. Quercetin hexosides, primarily present in SF-4, may also participate in ACE-inhibition in a competitive manner [25]. The available evidence suggests that the polyphenols in the fractions synergistically inhibited ACE, but certain polyphenols, particularly the dicaffeoylquinic acids, had a greater inhibitory effect than others.
The ACE inhibitory effect of SA-3 and SA-4 may be due to the significant presence of flavones and their derivatives, with SA-4 demonstrating higher inhibiting activity than SA-3. This difference in activity may be attributed to the relatively higher abundance of apigenin, luteolin, and chrysoeriol (Table 6). Luteolin has been identified as a flavonoid with antihypertensive properties in rat models, using mechanisms other than ACE inhibition [50], although it cannot be ruled out that it could exert this effect in vivo. Loizzo et al. [47] reported the ACE-inhibiting activity of various flavonoids, such as apigenin and luteolin, with similar IC50 values obtained for both (280 and 290 µM, respectively). Jenis et al. [73] also reported the ACE-inhibiting activity of apigenin and luteolin, extracted from Limonium michelsonii. Shukor et al. [49] compared the ACE-inhibiting activity of different flavonoids and found that the inhibitory effect of apigenin was lower than that of other flavonoids such as quercetin or kaempferol. As previously indicated, the presence of OH groups in the benzene ring is important to inhibit ACE by forming chelate complexes with the zinc ion or certain amino acids within the active center. In addition, the presence of a catechol group in the B-ring of polyphenols, as in the case of luteolin, has been described as an important factor in their ACE inhibitory capacity [74]. Parellada et al. [70] reported that a planar structure essential for the inhibition of metalloenzymes is conferred by the presence of a 2,3 double bond that conjugates the benzene A and B rings. To exert ACE inhibition, the three most abundant flavones identified satisfy the condition of having at least one OH group on each aromatic ring and a carbonyl group in position 4. Chrysoeriol has also been reported as ACE-inhibitor [75]. However, Geng et al. [72] indicated that its inhibitory activity may be reduced due to the methylation in the OH group at the 3′-position of the B-ring.

DPP-IV Inhibitory Activity

The high DPP-IV inhibitory capacity of SF-3 and SF-4 (Table 2) can be attributed to the presence of hydroxycinnamic acids. Although the two fractions had similar polyphenolic profiles, their concentration was different. SF-3 exhibited a significantly higher DPP-IV inhibitory activity and a significantly higher proportion of caffeoylquinic acid isomers. These compounds are potent DPP-IV inhibitors. In a recent study, Geng et al. [72] described the DPP-IV inhibitory capacity of 3- and 4-caffeoylquinic acids, and suggested that these compounds may have hypoglycaemic effects in vivo. The inhibitory effect of these compounds, as well as other hydroxycinnamic acids found in SF-3 and SF-4, occurs via competitive mechanisms. They bind to the active site by forming hydrogen bonds between their OH groups and (i) the OH groups of the serine side chain present in the active center, (ii) the NH2 group of an Arg of the active center and (iii) the C=O groups of Glu side chains [31,76]. Due to steric hindrance caused by the additional caffeoyl group, the dicaffeoylquinic acids found in the fractions, mainly in SF-4, have a weaker inhibitory effect. This obstacle prevents the formation of hydrogen bonds and hinders interaction with the active site of the enzyme [77]. Caffeic acid, found in both fractions at low levels, has been identified as a feeble inhibitor of DPP-IV. Flavonoids, present in both fractions but in low proportions, may have a role to play in DPP-IV inhibition. Thus, apigenin and luteolin have been reported as potent non-competitive DPP-IV inhibitors. These compounds inhibit DPP-IV through the formation of hydrogen bonds and pi interactions with specific residues within the DPP-IV active center [31]. In contrast, quercetin, present in SF-4 but at a very low concentration, exhibited weak inhibition of DPP-IV. Rutin lacks the ability to inhibit DPP-IV due to two sugar groups present in its structure that could impede steric binding to the active site [31]. All of these findings suggest that caffeolquinic acids are the main responsible for the DPP-IV inhibiting capacity of SF-3 and SF-4.

PEP Inhibitory Activity

SA-3 and SA-4 showed potent PEP-inhibitory activity at very low concentrations in the system (0.2 mg/mL). The ability of polyphenols to induce PEP inhibition has been scarcely described. Calvo et al. [28] reported the PEP inhibitory activity of an ice plant extract containing luteolin. This compound was detected in both SA-3 and SA-4, but in much greater abundance in SA-4 (Table 6), suggesting that this compound is likely the main one responsible for the PEP inhibitory activity [78]. The presence of two OH groups on the B-ring (catechol ring) of luteolin (Figure 4), and an OH group at the 7-position of the A-ring appears to be linked to the PEP-inhibiting mechanism [31,78]. Apigenin might also play a role in the inhibitory effect of the fractions, either as a free form or in the methoxylated and glycosylated forms. However, according to Lee et al. [78], luteolin has a higher PEP inhibitory activity compared to apigenin (whether in free form or glycosylated), suggesting that luteolin is responsible for the PEP inhibitory capacity of the fractions obtained from seaside arrowgrass extract.

4. Conclusions

Seaside arrowgrass and sea fennel are sources of polyphenol extracts that possess antioxidant capacity and have the potential to provide antihypertensive, hypoglycemic and nootropic benefits. The antioxidant and the potential antihypertensive and hypoglycemic properties of sea fennel extract are due to the presence of hydroxycinnamic acids, particularly chlorogenic acids. The antioxidant and the potential antihypertensive and nootropic properties of seaside arrowgrass are attributed to the presence of flavones and derivatives, mainly apigenin and luteolin. These plants are abundant along the Mediterranean and Atlantic coasts and thrive in saline soils, and their potential as a source of bioactive extracts could stimulate greater interest in their controlled cultivation and the development of agriculture in countries with limited arable land. The polyphenols present in these plants can be readily extracted and utilized as functional ingredients in a variety of foods. Their antioxidant properties also make them valuable assets in safeguarding lipids in food products from oxidation. Further work will be required to enhance polyphenol extraction and evaluate the impact of incorporating these compounds into food on their sensory properties. Also, it will be necessary to evaluate the effects of thermal processing on the bioactivity, to assess the bioavailability of the bioactive polyphenols after gastrointestinal digestion, as well as to analyze the quantity and composition of the extracts obtained from plants gathered at different seasons and locations. Finally, it will be essential to evaluate the cytotoxicity of these extracts to determine their potential as bioactive ingredients in functional foods.

Author Contributions

Conceptualization, O.M.-A.; methodology, O.M.-A.; software, M.M.C. and O.M.-A.; validation, formal analysis and investigation, O.M.-A.; resources, M.E.L.-C. and O.M.-A.; writing—original draft preparation, M.M.C., M.E.L.-C. and O.M.-A.; writing—review and editing, M.M.C., M.E.L.-C. and O.M.-A.; project administration, M.E.L.-C. and O.M.-A.; funding acquisition, M.E.L.-C. and O.M.-A. All authors have read and agreed to the published version of the manuscript.

Funding

Grants PID2020-116142RB-100 and AGL2014-52825-R funded by MCIN/AEI/10.13039/501100011033. Grant AGL2014-52825-R was also funded by ERDF, A way to make Europe.

Data Availability Statement

The datasets generated for this study are available on request from the corresponding author.

Acknowledgments

Authors thank the company Porto-Muiños, S.A. for supplying halophytes, and the National Center for Biotechnology Information (NCBI, USA) for maintaining free access to the PubChem database.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Faustino, M.V.; Faustino, M.A.F.; Pinto, D.C.G.A. Halophytic grasses, a new source of nutraceuticals? A review on their secondary metabolites and biological activities. Int. J. Mol. Sci. 2019, 20, 1067. [Google Scholar] [CrossRef]
  2. Kafi, M.; Khan, M.A. Crop and Forage Production Using Saline Waters; Centre for Science & Technology of Non-Aligned and other Developing Countries (NAM S&T Centre); Daya Publishing House: New Delhi, India, 2008; Volume 1. [Google Scholar]
  3. Li, L.; Zhao, Y.; Han, G.; Guo, J.; Meng, Z.; Chen, M. Progress in the study and use of seawater vegetables. J. Agric. Food Chem. 2020, 68, 5998–6006. [Google Scholar] [CrossRef]
  4. Flowers, T.J.; Galal, H.K.; Bromham, L. Evolution of halophytes: Multiple origins of salt tolerance in land plants. Funct. Plant Biol. 2010, 37, 604–612. [Google Scholar] [CrossRef]
  5. Mzoughi, Z.; Majdoub, H. Pectic polysaccharides from edible halophytes: Insight on extraction processes, structural characterizations and immunomodulatory potentials. Int. J. Biol. Macromol. 2021, 173, 554–579. [Google Scholar] [CrossRef]
  6. Lefèvre, G.; Rivière, C. Amaranthaceae halophytes from the French Flanders coast of the North Sea: A review of their phytochemistry and biological activities. Phytochem. Rev. 2020, 19, 1263–1302. [Google Scholar] [CrossRef]
  7. Petropoulos, S.A.; Karkanis, A.; Martins, N.; Ferreira, I.C.F.R. Edible halophytes of the Mediterranean basin: Potential candidates for novel food products. Trends Food Sci. Technol. 2018, 74, 69–84. [Google Scholar] [CrossRef]
  8. Ferreira, M.J.; Pinto, D.C.G.A.; Cunha, Â.; Silva, H. Halophytes as Medicinal Plants against human infectious diseases. Appl. Sci. 2022, 12, 7493. [Google Scholar] [CrossRef]
  9. Lopes, M.; Sanches-Silva, A.; Castilho, M.; Cavaleiro, C.; Ramos, F. Halophytes as source of bioactive phenolic compounds and their potential applications. Crit. Rev. Food Sci. Nutr. 2023, 63, 1078–1101. [Google Scholar] [CrossRef]
  10. Petropoulos, S.A.; Karkanis, A.; Martins, N.; Ferreira, I.C.F.R. Halophytic herbs of the Mediterranean basin: An alternative approach to health. Food Chem. Toxicol. 2018, 114, 155–169. [Google Scholar] [CrossRef] [PubMed]
  11. Ksouri, R.; Ksouri, W.M.; Jallali, I.; Debez, A.; Magne, C.; Hiroko, I.; Abdelly, C. Medicinal halophytes: Potent source of health promoting biomolecules with medical, nutraceutical and food applications. Crit. Rev. Biotechnol. 2012, 32, 289–326. [Google Scholar] [CrossRef]
  12. Kraouia, M.; Nartea, A.; Maoloni, A.; Osimani, A.; Garofalo, C.; Fanesi, B.; Ismaiel, L.; Aquilanti, L.; Pacetti, D. Sea Fennel (Crithmum maritimum L.) as an emerging crop for the manufacturing of innovative foods and nutraceuticals. Molecules 2023, 28, 4741. [Google Scholar] [CrossRef]
  13. Sánchez-Faure, A.; Calvo, M.M.; Pérez-Jiménez, J.; Martín-Diana, A.B.; Rico, D.; Montero, M.P.; Gómez-Guillén, M.C.; López-Caballero, M.E.; Martínez-Alvarez, O. Exploring the potential of common iceplant, seaside arrowgrass and sea fennel as edible halophytic plants. Food Res. Int. 2020, 137, 109613. [Google Scholar] [CrossRef] [PubMed]
  14. Maoloni, A.; Cardinali, F.; Mila, V. Microbiological safety and stability of novel green sauces made with sea fennel (Crithmum maritimum L.). Food Res. Inter. 2022, 157, 111463. [Google Scholar] [CrossRef] [PubMed]
  15. Sousa, G.; Alve, M.I.; Neves, M.; Tecelão, C.; Ferreira-Dias, S. Enrichment of sunflower oil with ultrasound-assisted extracted bioactive compounds from Crithmum maritimum L. Foods 2022, 11, 439. [Google Scholar] [CrossRef] [PubMed]
  16. Piatti, D.; Angeloni, S.; Maggi, F.; Caprioli, G.; Ricciutelli, M.; Arnoldi, L.; Bosisio, S.; Mombelli, G.; Drenaggi, E.; Sagratini, G. Comprehensive characterization of phytochemicals in edible sea fennel (Crithmum maritimum L., Apiaceae) grown in central Italy. J. Food Comp. Anal. 2023, 115, 104884. [Google Scholar] [CrossRef]
  17. Politeo, O.; Popović, M.; Bratinčević, M.V.; Kovačević, K.; Urlić, B.; Mekinić, I.G. Chemical profiling of Sea Fennel (Crithmum maritimum L., Apiaceae) essential oils and their isolation residual waste-waters. Plants 2023, 12, 214. [Google Scholar] [CrossRef]
  18. Zafeiropoulou, V.; Tomou, E.-M.; Douros, A.; Skaltsa, H. The effect of successive harvesting on the volatile constituents of two essential oils of cultivated populations of sea fennel (Crithmum maritimum L.) in Greece. J. Essent. Oil Bear. Plants 2021, 24, 1–11. [Google Scholar] [CrossRef]
  19. Souid, A.; Croce, C.M.D.; Frassinetti, S.; Gabriele, M.; Pozzo, L.M.; Ciardi, M.; Abdelly, C.; Ben Hamed, K.; Magné, C.; Longo, V. Nutraceutical potential of leaf hydro-ethanolic extract of the edible halophyte Crithmum maritimum L. Molecules 2021, 26, 5380. [Google Scholar] [CrossRef]
  20. Mekinić, I.G.; Blazěvić, I.; Mudnić, I.; Burčul, F.; Grga, M.; Skroza, D.; Jerčić, I.; Ljubenkov, I.; Boban, M.; Milos, M.; et al. Sea fennel (Crithmum maritimum L.): Phytochemical profile, antioxidative, cholinesterase inhibitory and vasodilatory activity. J. Food Sci. Technol. 2016, 53, 3104–3112. [Google Scholar] [CrossRef]
  21. Jallali, I.; Zaouali, Y.; Missaoui, I.; Smeoui, A.; Abdelly, C.; Ksouri, R. Variability of antioxidant and antibacterial effects of essential oils and acetonic extracts of two edible halophytes: Crithmum maritimum L. and Inula crithmoїdes L. Food Chem. 2014, 145, 1031–1038. [Google Scholar] [CrossRef]
  22. Lee, J.M.; Min-Jin, Y.; Grace, C.; Lee, M.S.; Park, Y.G.; Dae-Sung, L. Antioxidant and anti-inflammatory activity of six halophytes in Korea. Nat. Prod. Sci. 2018, 24, 40–46. [Google Scholar] [CrossRef]
  23. Boestfleisch, C.; Papenbrock, J. Changes in secondary metabolites in the halophytic putative crop species Crithmum maritimum L., Triglochin maritima L. and Halimione portulacoides (L.) Aellen as reaction to mild salinity. PLoS ONE 2017, 12, e0176303. [Google Scholar] [CrossRef] [PubMed]
  24. Kumar, N.; Lamba, S.; Kumar, A.; Kumar, P.; Mann, A.; Devi, D.S.; Pooja, P.; Kumari, A.; Rani, B. Antioxidant defence in halophytes under high salinity. In Halophytes and Climate Change: Adaptive Mechanisms and Potential Uses; Hasanuzzaman, E.M., Shabala, S., Fujita, M., Eds.; CAB International: Wallingford, UK, 2019. [Google Scholar]
  25. Chakraborty, R.; Roy, S. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. J. Integr. Med. 2021, 19, 478–492. [Google Scholar] [CrossRef] [PubMed]
  26. Borghi, C.; Cicero, A.F.; Agnoletti, D.; Fiorini, G. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? Eur. J. Intern. Med. 2023, 110, 10–15. [Google Scholar] [CrossRef] [PubMed]
  27. Chen, L.; Wang, L.; Shu, G.; Yuan, J.; Zhang, J.; Qin, S.; Li, J. Enhanced antihypertensive potential of fermented pomegranate juice: The contribution of phenolic compounds biotransformation and the resultant angiotensin-I-converting enzyme inhibition mechanism. Food Chem. 2023, 404, 134745. [Google Scholar] [CrossRef]
  28. Calvo, M.M.; Martín-Diana, A.B.; Rico, D.; López-Caballero, M.E.; Martínez-Álvarez, O. Antioxidant, antihypertensive, hypoglycaemic and nootropic activity of a polyphenolic extract from the halophyte Ice Plant (Mesembryanthemum crystallinum). Foods 2022, 11, 1581. [Google Scholar] [CrossRef]
  29. Song, F.; Tang, M.M.; Wang, H.; Zhang, Y.F.; Zhu, K.X.; Chen, X.A.; Chen, H.; Zhao, X.M. UHPLC-MS/MS identification, quantification of flavonoid compounds from Areca catechu L. extracts and in vitro evaluation of antioxidant and key enzyme inhibition properties involved in hyperglycemia and hypertension. Ind. Crops. Prod. 2022, 189, 115787. [Google Scholar] [CrossRef]
  30. Wijesekara, I.; Kim, S.-K. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Mar. Drugs 2010, 8, 1080–1093. [Google Scholar] [CrossRef]
  31. Fan, W.Z.; Tezuka, Y.; Komatsu, K.; Namba, T.; Kadota, S. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sacra S.H. Fu. Biol. Pharm. Bull. 1999, 22, 157–161. [Google Scholar] [CrossRef]
  32. Singh, A.-K.; Yadav, D.; Sharma, N.; Jin, J.-O. Dipeptidyl Peptidase (DPP)-IV inhibitors with antioxidant potential isolated from natural sources: A novel approach for the management of diabetes. Pharmaceuticals 2021, 14, 586. [Google Scholar] [CrossRef]
  33. Farias, D.D.; de Araujo, F.F.; Neri-Numa, I.A.; Pastore, G. M Antidiabetic potential of dietary polyphenols: A mechanistic review. Food Res. Int. 2021, 145, 110383. [Google Scholar] [CrossRef]
  34. Soukup, O.; Stralkova, R.; Mistova, T.; Popov, M.; Hejtmankova, A.; Lachman, J.; Klimova, B.; Kuca, K. Polyphenolic compound from Vitis vinifera L. have potential for the Alzheimer disease treatment. Lett. Drug. Des. Discov. 2017, 14, 853–859. [Google Scholar] [CrossRef]
  35. Sila, A.; Martinez-Alvarez, O.; Haddar, A.; Gómez-Guillén, M.C.; Nasri, M.; Montero, M.P.; Bougatef, A. Recovery, viscoelastic and functional properties of Barbel skin gelatine: Investigation of anti-DPP-IV and anti-prolyl endopeptidase activities of generated gelatine polypeptide. Food Chem. 2015, 168, 478–486. [Google Scholar] [CrossRef] [PubMed]
  36. Yoon, H.R.; Paik, Y.S. Antioxidative and prolyl endopeptidase inhibitory activities of the phenolic constituents isolated from Phellinus linteus. J. Korean Soc. Appl. Biol. Chem. 2010, 53, 652–656. [Google Scholar] [CrossRef]
  37. Gass, J.; Khosla, C. Prolyl endopeptidases. Cell. Mol. Life Sci. 2007, 64, 345–355. [Google Scholar] [CrossRef] [PubMed]
  38. Sentandreu, M.A.; Toldrá, F.A. Rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme. Food Chem. 2006, 97, 546–554. [Google Scholar] [CrossRef]
  39. Kähkönen, M.P.; Hopia, A.I.; Vuorela, H.J.; Rauha, J.-P.; Pihlaja, K.; Kujala, T.S.; Heinonen, M. Antioxidant activity of plant extracts containing phenolic compounds. J. Agric. Food Chem. 1999, 47, 3954–3962. [Google Scholar] [CrossRef]
  40. Houta, O.; Akrout, A.; Neffati, M.; Amri, H. Phenolic contents, antioxidant and antimicrobial potentials of Crithmum maritimum cultivated in Tunisia arid zones. J. Biol. Active Prod. Nature 2011, 1, 138–143. [Google Scholar] [CrossRef]
  41. Meot-Duros, L.; Magné, C. Antioxidant activity and phenol content of Crithmum maritimum L. leaves. Plant Physiol. Biochem. 2009, 47, 37–41. [Google Scholar] [CrossRef]
  42. Veršić Bratinčević, M.; Kovačić, R.; Popović, M.; Radman, S.; Generalić Mekinić, I. Comparison of Conventional and Green Extraction Techniques for the Isolation of Phenolic Antioxidants from Sea Fennel. Processes 2023, 11, 2172. [Google Scholar] [CrossRef]
  43. Sun, J.; Zhang, H.; Yin, G.Y.; Chen, L.Y.; Hu, C.Z. Extraction of polysaccharides from pumpkin by ultrasonic method and it’s primary antioxidant activities research. Adv. Mat. Res. 2011, 183–185, 1970–1974. [Google Scholar] [CrossRef]
  44. Kadoglidou, K.; Irakli, M.; Boutsika, A.; Mellidou, I.; Maninis, N.; Sarrou, E.; Georgiadou, V.; Tourvas, N.; Krigas, N.; Moysiadis, T.; et al. Metabolomic fingerprinting and molecular characterization of the rock samphire germplasm collection from the Balkan Botanic Garden of Kroussia, northern Greece. Plants 2022, 11, 573. [Google Scholar] [CrossRef] [PubMed]
  45. Nabet, N.; Boudries, H.; Chougui, N.; Loupassaki, S.; Souagui, S.; Burló, F.; Hernández, F.; Carbonell-Barrachina, A.A.; Madani, K.; Larbat, R. Biological activities and secondary compound composition from Crithmum maritimum aerial parts. Int. J. Food Prop. 2017, 20, 1843–1855. [Google Scholar] [CrossRef]
  46. Zengin, G.; Sinan, K.I.; Ak, G.; Mahomoodally, M.F.; Paksoy, M.Y.; Picot-Allain, C.; Glamocilja, J.; Sokovic, M.; Jekő, J.; Cziákyg, Z.; et al. Chemical profile, antioxidant, antimicrobial, enzyme inhibitory, and cytotoxicity of seven Apiaceae species from Turkey: A comparative study. Ind. Crops Prod. 2020, 153, 112572. [Google Scholar] [CrossRef]
  47. Loizzo, M.R.; Said, A.; Tundis, R.; Rashed, K.; Statti, G.A.; Hufner, A.; Menichini, F. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother. Res. 2007, 21, 32–36. [Google Scholar] [CrossRef]
  48. Men, R.; Li, N.; Xing, Y.; Tang, Y.; Tan, C.; Meng, F.; Zhang, J.; Ni, H.; Jia, X. Chemical constituents and ACE inhibitory activity of desert plant Suaeda physophora. Pall. Acta Pharm. Sin. B 2013, 3, 328–332. [Google Scholar] [CrossRef]
  49. Shukor, N.A.; Van Camp, J.; Gonzales, G.B.; Staljanssens, D.; Struijs, K.; Zotti, M.J.; Raes, K.; Smagghe, G. Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: A study of structure activity relationships. J. Agric. Food Chem. 2013, 61, 11832–11839. [Google Scholar] [CrossRef] [PubMed]
  50. Gai, Z.; Hu, S.; Gong, G.; Zhao, J. Recent advances in understanding dietary polyphenols protecting against hypertension. Trends Food Sci. Technol. 2023, 138, 685–696. [Google Scholar] [CrossRef]
  51. Li, H.F.; Chen, S.A.; Wu, S.N. Evidence for the stimulatory effect of resveratrol on Ca(2+)-activated K+ current in vascular endothelial cells. Cardiovasc. Res. 2000, 45, 1035–1045. [Google Scholar] [CrossRef]
  52. Sharifi, A.M.; Darabi, R.; Akbarloo, N. Study of antihypertensive mechanism of Tribulus terrestris in 2K1C hypertensive rats: Role of tissue ACE activity. Life Sci. 2003, 73, 2963–2971. [Google Scholar] [CrossRef]
  53. Phillips, O.A.; Mathew, K.T.; Oriowo, M.A. Antihypertensive and vasodilator effects of methanolic and aqueous extracts of Tribulus terrestris in rats. J. Ethnopharmacol. 2006, 104, 351–355. [Google Scholar] [CrossRef] [PubMed]
  54. Murshid, S.S.A.; Atoum, D.; Abou-Hussein, D.R.; Abdallah, H.M.; Hareeri, R.H.; Almukadi, H.; Edrada-Ebel, R. Genus Salsola: Chemistry, Biological Activities and Future Prospective—A Review. Plants 2022, 11, 714. [Google Scholar] [CrossRef] [PubMed]
  55. Gattringer, J.; Ndogo, O.E.; Retzl, B.; Ebermann, C.; Gruber, C.W.; Hellinger, R. Cyclotides isolated from violet plants of Cameroon are inhibitors of human Prolyl Oligopeptidase. Front. Pharmacol. 2021, 12, 707596. [Google Scholar] [CrossRef] [PubMed]
  56. Marques, M.R.; Stuker, C.; Kichik, N.; Tarrago, T.; Giralt, E.; Morel, A.F.; Dalcol, I.I. Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers. Fitoterapia 2010, 81, 552–556. [Google Scholar] [CrossRef]
  57. Tarrago, T.; Kichik, N.; Segui, J.; Giralt, E. The natural product berberine is a human prolyl oligopeptidase inhibitor. Chem. Med. Chem. 2007, 2, 354–359. [Google Scholar] [CrossRef] [PubMed]
  58. Maoloni, A.; Pirker, T.; Pferschy-Wenzig, E.M.; Aquilanti, L.; Bauer, R. Characterization of potentially health-promoting constituents in sea fennel (Crithmum maritimum) cultivated in the Conero Natural Park (Marche region, Central Italy). Pharm. Biol. 2023, 61, 1030–1040. [Google Scholar] [CrossRef]
  59. Alemán, A.; Marín-Peñalver, D.; de Palencia, P.F.; Gómez-Guillén, M.d.C.; Montero, P. Anti-Inflammatory properties, bioaccessibility and intestinal absorption of Sea fennel (Crithmum maritimum) extract encapsulated in soy phosphatidylcholine liposomes. Nutrients 2022, 14, 210. [Google Scholar] [CrossRef]
  60. Siracusa, L.; Kulisic-Bilusic, T.; Politeo, O.; Krause, I.; Dejanovic, B.; Ruberto, G. Phenolic composition and antioxidant activity of aqueous infusions from Capparis spinosa L. and Crithmum maritimum L. before and after submission to a two-step in vitro digestion model. J. Agric. Food Chem. 2011, 59, 12453–12459. [Google Scholar] [CrossRef]
  61. Xu, J.G.; Hu, Q.P.; Liu, Y. Antioxidant and DNA-Protective activities of chlorogenic acid isomers. J. Agric. Food Chem. 2012, 60, 11625–11630. [Google Scholar] [CrossRef]
  62. Yang, J.; Guo, J.; Yuan, J. In vitro antioxidant properties of rutin. LWT Food Sci. Technol. 2008, 41, 1060–1066. [Google Scholar] [CrossRef]
  63. Lang, Y.; Gao, N.; Zang, Z.; Meng, X.; Lin, Y.; Yang, S.; Yang, Y.; Jin, Z.; Li, B. Classification and antioxidant assays of polyphenols: A review. J. Fut. Foods 2024, 4, 193–204. [Google Scholar] [CrossRef]
  64. Imran, M.; Saeed, F.; Hussain, G.; Imran, A.; Mehmood, Z.; Gondal, T.A.; El-Ghorab, A.; Ahmad, I.; Pezzani, R.; Arshad, M.U.; et al. Myricetin: A comprehensive review on its biological potentials. Food Sci. Nutr. 2021, 9, 5854–5868. [Google Scholar] [CrossRef]
  65. Le, K.; Chiu, F.; Ng, K. Identification and quantification of antioxidants in Fructus lycii. Food Chem. 2007, 105, 353–363. [Google Scholar] [CrossRef]
  66. Kashyap, P.; Shikha, D.; Thakur, M.; Aneja, A. Functionality of apigenin as a potent antioxidant with emphasis on bioavailability, metabolism, action mechanism and in vitro and in vivo studies: A review. J. Food Biochem. 2022, 46, e13950. [Google Scholar] [CrossRef] [PubMed]
  67. Shen, N.; Wang, T.; Gan, Q.; Liu, S.; Wang, L.; Jin, B. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity. Food Chem. 2022, 383, 132531. [Google Scholar] [CrossRef] [PubMed]
  68. Ahmadi, S.M.; Farhoosh, R.; Sharif, A.; Rezaie, M. Structure-antioxidant activity relationships of luteolin and catechin. J Food Sci. 2020, 85, 298–305. [Google Scholar] [CrossRef]
  69. Agunloye, O.M.; Oboh, G.; Ademiluyi, A.O.; Ademosun, A.O.; Akindahunsi, A.A.; Oyagbemi, A.A.; Omobowale, T.O.; Ajibade, T.O.; Adedapo, A.A. Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: Mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats. Biomed. Pharmacother. 2019, 109, 450–458. [Google Scholar] [CrossRef]
  70. Parellada, J.; Suarez, G.; Guinea, M. Inhibition of zinc metallopeptidases by flavonoids and related phenolic compounds, structure-activity relationships. J. Enzyme Inhib. 1998, 13, 347–359. [Google Scholar] [CrossRef]
  71. Ende, C.; Gebhardt, R. Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids. Planta Med. 2004, 70, 1006–1008. [Google Scholar] [CrossRef]
  72. Geng, F.; He, Y.; Yang, L.; Wang, Z. A rapid assay for angiotensin-converting enzyme activity using ultra-performance liquid chromatography-mass spectrometry. Biomed. Chromatogr. 2010, 24, 312–317. [Google Scholar] [CrossRef]
  73. Jenis, J.; Kim, J.Y.; Uddin, Z.; Song, Y.H.; Lee, H.H.; Park, K.H. Phytochemical profile and angiotensin I converting enzyme (ACE) inhibitory activity of Limonium michelsonii Lincz. J. Nat. Med. 2017, 71, 650–658. [Google Scholar] [CrossRef] [PubMed]
  74. Guerrero, L.; Castillo, J.; Quinones, M.; Garcia-Vallve, S.; Arola, L.; Pujadas, G.; Muguerza, B. Inhibition of angiotensin-converting enzyme activity by flavonoids: Structure-activity relationship studies. PLoS ONE 2012, 7, e49493. [Google Scholar] [CrossRef] [PubMed]
  75. Xing, Y.; Liao, J.; Tang, Y.; Zhang, P.; Tan, C.; Ni, H.; Wu, X.Q.; Li, N.; Jia, X.G. ACE and platelet aggregation inhibitors from Tamarix hohenackeri Bunge (host plant of Herba Cistanches) growing in Xinjiang. Pharmacogn. Mag. 2014, 10, 111–117. [Google Scholar] [CrossRef] [PubMed]
  76. Wu, M.; Yang, Q.; Wu, Y.; Ouyang, J. Inhibitory effects of acorn (Quercus variabilis Blume) kernel-derived polyphenols on the activities of α-amylase, α-glucosidase, and dipeptidyl peptidase IV. Food Biosci. 2021, 43, 101224. [Google Scholar] [CrossRef]
  77. Rozano, L.; Zawawi, M.R.A.; Ahmad, M.A.; Jaganath, I.B. Computational analysis of Gynura bicolor bioactive compounds as Dipeptidyl Peptidase-IV inhibitor. Adv. Bioinform. 2017, 3, 154–196. [Google Scholar] [CrossRef]
  78. Lee, K.-H.; Kwak, J.H.; Lee, K.-B.; Song, K.-S. Prolyl Endopeptidase inhibitors from Caryophylli Flos. Arch. Pharm. Res. 1998, 21, 207–211. [Google Scholar] [CrossRef]
Foods 12 03886 g001
Figure 1. Elution profile of the sea fennel extract measured at 360 and 280 nm. Four fractions were collected (red lines): SF-1 (5–7.2 min), SF-2 (7.3–11 min), SF-3 (20.5–23.4 min), SF-4 (23.7–29 min).
Figure 1. Elution profile of the sea fennel extract measured at 360 and 280 nm. Four fractions were collected (red lines): SF-1 (5–7.2 min), SF-2 (7.3–11 min), SF-3 (20.5–23.4 min), SF-4 (23.7–29 min).
Foods 12 03886 g001
Foods 12 03886 g002
Figure 2. Elution profile of the seaside arrowgrass extract measured at 360 and 280 nm. Four fractions were collected (red lines): SA-1 (5–7.3 min), SA-2 (7.5–11 min), SA-3 (24–27.5 min) and SA-4 (28–31 min).
Figure 2. Elution profile of the seaside arrowgrass extract measured at 360 and 280 nm. Four fractions were collected (red lines): SA-1 (5–7.3 min), SA-2 (7.5–11 min), SA-3 (24–27.5 min) and SA-4 (28–31 min).
Foods 12 03886 g002
Foods 12 03886 g003
Figure 3. Structure of the most abundant polyphenols in the bioactive fractions from the sea fennel extract. (A) 3-Caffeoylquinic acid; (B) 3-Feruloylquinic acid; (C) 3-Coumaroylquinic acid; (D) 3,4-dicaffeoylquinic acid; (E) Quercetin 3-O-hexoside (isoquercitrin); (F) Rutin. The structures in (A–E) correspond to one of the isomers potentially present in the fractions. Structures were from PubChem database.
Figure 3. Structure of the most abundant polyphenols in the bioactive fractions from the sea fennel extract. (A) 3-Caffeoylquinic acid; (B) 3-Feruloylquinic acid; (C) 3-Coumaroylquinic acid; (D) 3,4-dicaffeoylquinic acid; (E) Quercetin 3-O-hexoside (isoquercitrin); (F) Rutin. The structures in (A–E) correspond to one of the isomers potentially present in the fractions. Structures were from PubChem database.
Foods 12 03886 g003
Foods 12 03886 g004
Figure 4. Structure of polyphenols in the bioactive fractions from the seaside arrowgrass extract. (A) apigenin; (B) apigenin-7-glucoside; (C) luteolin; (D) chrysoeriol. The structure in (B) corresponds to one of the isomers potentially present in the fractions. Structures were from PubChem database.
Figure 4. Structure of polyphenols in the bioactive fractions from the seaside arrowgrass extract. (A) apigenin; (B) apigenin-7-glucoside; (C) luteolin; (D) chrysoeriol. The structure in (B) corresponds to one of the isomers potentially present in the fractions. Structures were from PubChem database.
Foods 12 03886 g004
Table 1. Total phenols content, antioxidant activity and enzymatic activity inhibitions (0.5 mg/mL, dried weight) of the sea fennel and seaside arrowgrass extracts. The determinations were performed using dried samples. Different letters in the same row indicate significant differences (p < 0.05).
Table 1. Total phenols content, antioxidant activity and enzymatic activity inhibitions (0.5 mg/mL, dried weight) of the sea fennel and seaside arrowgrass extracts. The determinations were performed using dried samples. Different letters in the same row indicate significant differences (p < 0.05).
Sea FennelSeaside Arrowgrass
Total phenols content (mEq GA/g)23.6 ± 0.1 a21.2 ± 0.1 b
Antioxidant activity
ABTS (mg Eq ascorbic acid/g)20.6 ±0.4 a17.4 ± 0.6 b
FRAP (mEq Mohr’s salt/g)269.0 ± 12.0 a169.6 ± 5.8 b
Enzymatic activity inhibition
ACE (%)79.6 ± 0.9 a90.2 ± 1.3 b
PEP (%)74.7 ± 3.0 a92.8 ± 2.2 b
DPP-IV (%)72.7 ± 1.1 a68.4 ± 1.2 b
Table 2. Total phenols content, antioxidant activity and enzymatic activity inhibitions of the sea fennel and seaside arrowgrass fractions. Different letters in the same row indicate significant differences among samples.
Table 2. Total phenols content, antioxidant activity and enzymatic activity inhibitions of the sea fennel and seaside arrowgrass fractions. Different letters in the same row indicate significant differences among samples.
AssaySea FennelSeaside Arrowgrass
SF-1SF-2SF-3SF-4SA-1SA-2SA-3SA-4
Total phenols content (mEq GA/g)9.1 ± 0.97 a41.9 ± 4.2 c225.1 ± 15.7 g155.4 ± 8.4 f7.5 ± 4.0 a21.3 ± 0.7 b104.9 ± 8.4 d125.5 ± 7.7 e
Antioxidant activity
ABTS (mg Eq ascorbic acid/g)8.8 ± 0.6 b32.8 ± 2.6 d177.4 ± 11.6 h124.4 ± 11.6 g4.7 ± 0.6 a12.0 ± 0.9 c53.6 ± 3.2 e90.3 ± 5.5 f
FRAP (mEq Mohr’s salt /g)248 ± 4 a636 ± 14 c3233 ± 129 g2712 ± 122 f248 ± 12 a354 ± 13 b1048 ± 14 d1701 ± 38 e
Enzymatic activity inhibition
ACE (%)28.3 ± 2.1 a56.7 ± 0.3 c92.2 ± 0.1 g90.0 ± 1.1 f53.8 ± 0.7 b68.7 ± 0.7 d82.0 ± 1.0 e91.0 ± 0.2 f
DPP-IV (%)8.99 ± 2.7 ab26.8 ± 8.6 c82.1 ± 2.8 g76.1 ± 2.8 f5.56 ± 0.3 a12.3 ± 1.3 b58.2 ± 1.4 e49.7 ± 0.8 d
PEP (%)No activity7.9 ± 2.8 a52.2 ± 2.3 d45.4 ± 0.9 c12.5 ± 5.2 b7.5 ± 1.1 a97.3 ± 0.3 e98.6 ± 0.2 f
Table 3. Polyphenolic compounds in fractions SF-3 and SF-4 from sea fennel. The relative area refers to the total compound area. Masses were obtained through negative mode analysis.
Table 3. Polyphenolic compounds in fractions SF-3 and SF-4 from sea fennel. The relative area refers to the total compound area. Masses were obtained through negative mode analysis.
CompoundFractionExperimental MassCalculated MassError (ppm)MS/MS IonsRt (min)Relative Abundance
Phenolic acids
Hydroxybenzoic acidSF−3137.0238137.0238−3.5392, 93, 108, 118, 136, 1378.133.60
SF−4 137.0246−1.63 8.150.30
Hydroxycinnamic acids and derivatives
Caffeic acidSF−3179.0350179.0352−0.5779, 91, 133, 134, 13511.071.40
SF−4 179.03550.48 11.092.23
Caffeoylquinic acidSF−3353.0878353.0876−0.04135, 161, 173, 179, 1918.781.69
SF−4 353.0883−1.46 8.481.24
Caffeoylquinic acidSF−3353.0878353.0884−1.45135, 161, 179, 191, 2179.5520.26
SF−4 353.0886−1.79 9.571.36
Caffeoylquinic acidSF−3353.0878353.08751.30135, 161, 173, 179, 191, 35310.367.09
SF−4 353.0886−2.64 10.531.28
Caffeoylquinic acidSF−3353.0878353.0875−2.40161, 179, 191, 35312.2212.68
SF−4 353.08751.11 12.255.48
Dicaffeoylquinic acidSF−3515.1195515.1210−2.12135, 161, 173, 179, 191, 335, 35320.570.62
SF−4 515.1209−2.74 20.553.60
Dicaffeoylquinic acidSF−3515.1195515.1201−0.94135, 179, 191, 335, 35321.371.43
SF−4 515.1218−4.32 21.375.58
Dicaffeoylquinic acidSF−3515.1195515.1198−0.71135, 173, 179, 191, 335, 35321.930.14
SF−4 515.1202−2.22 21.921.65
Dicaffeoylquinic acidSF−3515.1195515.1207−1.93135,173,179,191,53522.890.12
SF−4 515.1212−3.33 22.872.29
Coumaroylquinic acidSF−3337.0929337.0912−4.9893, 119, 137, 163, 173, 191,11.731.87
SF−4 337.0928−0.06 11.730.57
Coumaroylquinic acidSF−3337.0929337.0948−4.7393, 119, 145, 163, 173, 19112.5914.40
SF−4 337.0935−1.70 12.5913.91
Coumaroylquinic acidSF−3337.0929337.0929−4.4693, 119, 137, 163, 173, 19113.001.83
SF−4 337.0939−2.29 13.001.46
Coumaroylquinic acidSF−3337.0929337.0927−0.87137, 145, 163, 173, 19115.1912.08
SF−4 337.0939−5.92 15.1913.96
Feruloylquinic acidSF−3367.0350367.1042−1.84134, 173, 191, 19314.196.28
SF−4 367.1044−2.18 14.228.77
Feruloylquinic acidSF−3367.1035367.1052−4.41134, 173, 191, 19316.346.28
SF−4 367.10282.14 16.334.49
Coumaroyl hexosideSF−3325.0929325.0938−2.59119, 120, 163, 164, 165, 3259.772.86
Coumarins and derivatives
EsculetinSF−3177.0188177.0192−0.36105, 107, 121, 133, 14910.631.10
SF−4 177.0918−2.57 10.630.38
Flavonols and derivatives
QuercetinSF−4301.0354301.0356−0.4265, 83, 107, 121, 151, 179, 30128.911.16
Quercetin hexosideSF−3463.0876463.0883−0.07151, 179, 243, 255, 271, 300, 30118.410.83
SF−4 463.089−1.82 18.426.47
Quercetin hexosideSF−3463.0876463.0895−2.72149, 179, 271, 300, 30118.560.41
SF−4 463.0892−1.93 18.655.68
RutinSF−3609.1461609.14551.43151, 271, 300, 30118.022.37
SF−4 606.14551.43 18.027.08
MyricetinSF−4317.0303317.02981.56109, 125, 151, 152, 163, 179, 227, 271, 31714.032.10
Flavones and derivatives
ApigeninSF−3269.0455269.0455−0.42107, 117, 149, 151, 225, 26933.020.24
SF−4 269.0466−3.77 33.132.61
Apigenin hexosideSF−3431.0984431.0995−1.82270, 283, 311, 312, 34117.900.17
SF−4 431.09820.51 17.890.31
Apigenin hexosideSF−3431.0984431.09840.58No fragment detected18.080.05
SF−4 431.0993−2.42 18.010.09
DiosminSF−3607.1668607.1681−1.98284, 285, 299, 300, 30122.100.10
SF−4 607.16670.66 22.101.75
LuteolinSF−3285.0405285.04080.04107, 133, 149, 151, 175, 199, 21728.760.07
SF−4 285.04011.33 28.743.54
ChrysoeriolSF−3299.0561299.05561.12256, 284, 29933.660.03
SF−4 299.0570−2.83 33.700.48
DiosmetinSF−4299.0561299.05522.53107, 133, 151, 227, 239, 255, 256, 28433.810.18
Table 4. Summarized polyphenol composition of fractions SF-3 and SF-4 from sea fennel, expressed in percentage.
Table 4. Summarized polyphenol composition of fractions SF-3 and SF-4 from sea fennel, expressed in percentage.
CompoundsSF-3 (%)SF-4 (%)
Phenolic acids (Hydroxybenzoic acid)3.600.30
Hydroxycinnamic acids and derivatives91.0367.87
Caffeic acid1.402.23
Caffeoylquinic acids41.729.36
Dicaffeoylquinic acids2.3113.12
Coumaroylquinic acids30.1829.90
Feruloylquinic acids12.5613.26
Coumaroyl hexosides2.860.00
Coumarins and derivatives (Esculetin)1.100.38
Flavonols and derivatives3.6122.49
Quercetin0.001.16
Quercetin hexosides1.2412.15
Rutin2.377.08
Myricetin0.002.10
Flavones and derivatives0.668.96
Apigenin0.242.61
Apigenin hexosides0.220.40
Diosmin0.101.75
Luteolin0.073.54
Chrysoeriol0.030.48
Diosmetin0.000.18
Table 5. Polyphenolic compounds in fractions SA-3 and SA-4 from seaside arrowgrass. The relative area refers to the total area of the compounds. Masses were obtained in the negative mode analysis.
Table 5. Polyphenolic compounds in fractions SA-3 and SA-4 from seaside arrowgrass. The relative area refers to the total area of the compounds. Masses were obtained in the negative mode analysis.
CompoundFractionExperimental MassCalculated MassError (ppm)MS/MS IonsRt (min)Relative Abundance
Phenolic acids
Hydroxybenzoic acidSA−3137.0238137.0247−1.7892, 93, 108, 118, 136, 1378.150.36
SA−4 137.0251−1.02 8.170.01
Hydroxycinnamic acids and derivatives
Caffeic acidSA−3179.0350179.0359−3.5691, 133, 134, 13511.050.91
Coumarins and derivatives
EsculetinSA−3177.0188177.01900.51105, 107, 121, 133, 14910.580.87
Flavones and derivatives
ApigeninSA−3269.0455269.0458−0.71107, 117, 143, 151, 159, 227, 24133.086.96
SA−4 269.04520.98 33.0552.41
Apigenin−hexoside SA−3431.0984431.09771.58270, 283, 311, 312, 34117.8929.85
SA−4 431.0982−1.19 17.900.04
Apigenin−hexosideSA−3431.0984431.0988−0.67270, 283, 311, 312, 34118.0250.62
SA−4 431.0994−2.23 18.020.07
LuteolinSA−3285.0405285.04011.45107, 133, 149, 151, 175, 199, 21728.688.48
SA−4 285.03991.92 28.6634.66
ChrysoeriolSA−3299.0561299.05561.12256, 284, 29933.661.95
SA−4 299.0563−0.78256, 284, 285, 29933.6712.81
Table 6. Summarized polyphenol composition of SA-3 and SA-4 from seaside arrowgrass, expressed in percentage.
Table 6. Summarized polyphenol composition of SA-3 and SA-4 from seaside arrowgrass, expressed in percentage.
CompoundsSA-3 (%)SA-4 (%)
Phenolic acids (Hydroxybenzoic acid)0.360.01
Hydroxycinnamic Acids and derivatives (Caffeic acid)0.910.00
Coumarins and derivatives (Esculetin)0.870.00
Flavones and derivatives97.8699.99
Apigenin6.9652.41
Apigenin hexoside80.470.11
Luteolin8.4834.66
Chrysoeriol1.9512.81
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Calvo, M.M.; López-Caballero, M.E.; Martínez-Alvarez, O. Identification of Polyphenols in Sea Fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) Extracts with Antioxidant, ACE-I, DPP-IV and PEP-Inhibitory Capacity. Foods 2023, 12, 3886. https://doi.org/10.3390/foods12213886

AMA Style

Calvo MM, López-Caballero ME, Martínez-Alvarez O. Identification of Polyphenols in Sea Fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) Extracts with Antioxidant, ACE-I, DPP-IV and PEP-Inhibitory Capacity. Foods. 2023; 12(21):3886. https://doi.org/10.3390/foods12213886

Chicago/Turabian Style

Calvo, Marta María, María Elvira López-Caballero, and Oscar Martínez-Alvarez. 2023. "Identification of Polyphenols in Sea Fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) Extracts with Antioxidant, ACE-I, DPP-IV and PEP-Inhibitory Capacity" Foods 12, no. 21: 3886. https://doi.org/10.3390/foods12213886

APA Style

Calvo, M. M., López-Caballero, M. E., & Martínez-Alvarez, O. (2023). Identification of Polyphenols in Sea Fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) Extracts with Antioxidant, ACE-I, DPP-IV and PEP-Inhibitory Capacity. Foods, 12(21), 3886. https://doi.org/10.3390/foods12213886

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop